Augmedix, Inc. (AUGX)
2.350
0.00 (0.00%)
Inactive · Last trade price on Oct 1, 2024

Augmedix Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Augmedix stock had an average target of $5.25, with a low estimate of $5.00 and a high estimate of $5.50.

Price Target: $5.25 (+123.40%)
Analyst Consensus: Buy

Price Target

TargetLowAverageMedianHigh
Price$5.00$5.25n/a$5.50
Change+112.77%+123.40%n/a+134.04%

Analyst Ratings

The average analyst rating for Augmedix stock from 4 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available
RatingOct 2026
Strong Buyn/a
Buyn/a
Holdn/a
Selln/a
Strong Selln/a
Totaln/a

Financial Forecast

Revenue This Year
54.16M
from 44.86M
Increased by 20.75%
Revenue Next Year
68.55M
from 54.16M
Increased by 26.57%
EPS This Year
-0.54
from -0.44
EPS Next Year
-0.48
from -0.54
Fiscal YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Period EndingDec 31, 2019Dec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue
14.11M16.48M22.17M30.93M44.86M54.16M68.55M
Revenue Growth
30.44%16.84%34.47%39.56%45.01%20.75%26.57%
EPS
-22.24-2.22-0.60-0.65-0.44-0.54-0.48
No. Analysts
-----54

Revenue Forecast

Revenue202420252026
High56.1M75.5M
Avg54.2M68.6M
Low51.2M63.3M

Revenue Growth

Revenue Growth202420252026
High
25.1%
39.4%
Avg
20.7%
26.6%
Low
14.0%
16.9%

EPS Forecast

EPS202420252026
High-0.47-0.46
Avg-0.54-0.48
Low-0.60-0.50

EPS Growth

EPS Growth202420252026
High--
Avg--
Low--